Trump’s much-hyped $765 million plan to turn Eastman Kodak Company into pharmaceutical maker put on hold after concerns over insider trading.

CoronavirusThe EconomyCorruption
Written By 1,000 Hours of Outrage
 
004XIM-CP-RC - Isaiah King.jpg

Cookout by Ryan Ferland

Instagram: @ferland_ink

Source: Forbes

Outrage 768 of 1000

 
1,000 Hours of Outrage
Previous

The Trump Administration considered lifting Russian sanctions immediately after the inauguration.
Next

EPA repealed rules meant to reduce leaking and venting of powerful greenhouse gases.